Checking out or checking in? Jin Jiang can’t decide
Three years after privatizing its Hong Kong-listed shares, storied hotelier Jin Jiang has rolled out plans to re-list on the city’s stock exchange Key Takeaways: Jin Jiang has applied to…
NEWS WRAP: Atour’s revenue grows 30% on strong gains for retail business
The hotel operator’s retail business grew 67% in the first quarter, and now accounts for more than a third of its revenue By Doug Young Atour Lifestyle Holdings Ltd.…
Trip.com’s overseas journey cruises ahead, as profit wobbles
China’s leading online travel agent, formerly known as Ctrip, wants to be a global player, but spending on such efforts could erode its profits Key Takeaways: Trip.com’s revenue rose 16%…
Tongcheng beefs up its hotel management, as Wanda buys more time
China’s third-largest online travel company is buying the hotel management unit of a former highflying operator now struggling to stay one step ahead of its creditors Key Takeaways Tongcheng has…
Atour relies on network expansion to counter economic slowdown
The hotel operator’s revenue rose 55% last year, but it forecast the growth would slow to about half that level in 2025 Key Takeaways: Atour’s revenue rose 38.5% in the…
‘Revenge travel’ slowdown puts damper on Trip.com’s banner year
After delivering impressive results for 2024, China’s leading online travel platform said it is confident of more growth in 2025 Key Takeaways: Trip.com’s reported its profit grew by a robust…
BRIEF: China Tourism Group Duty Free’s revenue, profit decline in 2024
Duty free store operator China Tourism Group Duty Free Corp. Ltd. (1880.HK) said on Thursday its revenue and profit both dropped by double-digit amounts last year, as Chinese consumers reined…
Recent Articles
Trip.com’s overseas journey cruises ahead, as profit wobbles
9961.HK
TCOM.US
Tongcheng beefs up its hotel management, as Wanda buys more time
0780.HK
0169.HK
RELATED ARTICLES
-
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK -
BRIEF: Fosun Tourism may have dropped into the red last year
1992.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
2196.HK 600196.SHG
-
‘Revenge travel’ slowdown puts damper on Trip.com’s banner year
9961.HK
